| ||
Appellate Ruling Exposes Long-Running Tension In Pharmaceutical Regulation Forbes A federal appellate panel in New York handed the pharmaceutical industry a significant victory on Monday that could have large ramifications by questioning one of the bedrocks underlying the industry's regulation. In a 2-1 ruling, the Second Circuit ... See all stories on this topic » | ||
Obamacare architect leaves White House for pharmaceutical industry job The Guardian When the legislation that became known as "Obamacare" was first drafted, the key legislator was the Democratic Chairman of the Senate Finance Committee, Max Baucus, whose committee took the lead in drafting the legislation. As Baucus himself ... See all stories on this topic » | ||
US pharmaceutical giant ready to invest $500 million in Russia Russia Beyond The Headlines In 2011, the analytical company Pharmexpert estimated Petrovax Pharm's turnover to be at $98 million, ranking it 12th among domestic pharmaceutical producers. In 2008, the European Bank for Reconstruction and Development (EBRD) acquired a minority ... See all stories on this topic » | ||
| ||
Pharmaceutical industry concentrates in Russia's Kaluga region Pravda Prospects of pharmacology were discussed in the Kaluga region within the scope of the third Innovation Forum "PharmEvolution: Localization of Pharmaceutical Production and Research in Russia. Practice, Trends and Prospects." The forum was held in the ... See all stories on this topic » | ||
Teva Pharmaceutical Industries Breaks Above 200-Day Moving Average ... Forbes In trading on Tuesday, shares of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) crossed above their 200 day moving average of $41.35, changing hands as high as $41.61 per share. Teva Pharmaceutical Industries Ltd shares are currently trading up ... See all stories on this topic » | ||
Pharmaceutical Industry Employs "AstroTurf," Not Grassroots, to Push ... Truth-Out Psychiatric groups like the Depression and Bipolar Support Alliance, (which gets half its funding from the pharmaceutical industry), and the National Alliance on Mental Illness (NAMI), (which received $23 million in just two years from the industry ... See all stories on this topic » | ||
La Jolla Pharmaceutical Company Announces FDA Approval of IND Marketwire (press release) SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - La Jolla Pharmaceutical Company ( OTCQB : LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics that target galectin-3, announced today that the FDA Division of Cardiovascular and ... See all stories on this topic » | ||
Pharmaceutical Compliance Teams' Primary Responsibility: Creating and ... The Herald | HeraldOnline.com RESEARCH TRIANGLE PARK, N.C. — Creating standard operating procedures (SOPs) and conducting regulatory intelligence are the two most expensive and time-consuming responsibilities of a pharmaceutical compliance team, according to a new study ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment